A Phase I, open-label, single-dose, fixed-sequence, two-part study to evaluate the effect of itraconazole and carbamazepine on fenebrutinib pharmacokinetics in healthy subjects
Latest Information Update: 05 Sep 2024
At a glance
- Drugs Carbamazepine (Primary) ; Fenebrutinib (Primary) ; Itraconazole (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors Genentech
Most Recent Events
- 17 Jul 2024 Status changed from not yet recruiting to recruiting.
- 24 Jun 2024 New trial record
- 17 Jun 2024 Status changed from recruiting to active, no longer recruiting.